Johnson & Johnson

American multinational pharmaceutical and consumer goods corporation

Johnson & Johnson ▸ Facts ▸ Comments ▸ News ▸ Videos

Johnson & Johnson (J&J) is an American multinational pharmaceutical, biotechnology, and medical technologies corporation headquartered in New Brunswick, New Jersey, and publicly traded on the New York Stock Exchange. Its common stock is a component of the Dow Jones Industrial Average, and the company is ranked No. 40 on the 2023 Fortune 500 list of the largest United States corporations. In 2023, the company was ranked 40th in the Forbes Global 2000. Johnson & Johnson has a global workforce of approximately 130,000 employees who are led by the company's current chairman and chief executive officer, Joaquin Duato.

0 shares	Share Tweet Save Post Send

You Might Like

After court win to make baby powder, J&J gives up licence Three years since ceasing production of its talc-based powders in the US and Canada, pharmaceutical giant Johnson and Johnson recently surrendered its licence to manufacture baby powder in its Mumbai.. IndiaTimes - Published on July 13, 2023
Johnson & Johnson agrees to pay $8.9bn to settle claims that talc caused cancer Johnson & Johnson (J&J) has agreed to pay almost $9bn (£7.2bn) to settle tens of thousands of lawsuits alleging its talc caused cancer. Sky News - Published on April 5, 2023
Johnson & Johnson’s set to lose patent on key TB drug in July In one of the most-watched patent cases in recent times, the Indian Patent Office on Thursday rejected American giant Johnson & Johnson’s (J&J) attempt to extend its monopoly on life-saving TB drug.. IndiaTimes - Published on March 23, 2023

HC quashes J&J baby powder manufacture ban over FDA test delay IndiaTimes - Published on January 11, 2023
Make, but don't sell: HC on J&J powder The Bombay HC on Wednesday ordered for fresh testing of Johnson & Johnson baby powder samples and permitted the company to manufacture the product but to not sell it, as per the Maharashtra government.. IndiaTimes - Published on November 17, 2022
Maharashtra FDA cancels Johnson & Johnson baby powder licence over poor quality The judgment was made after the Central Drugs Laboratory in Kolkata agreed with the Maharashtra FDA's 2019 report deeming the goods sub-standard. DNA - Published on September 17, 2022

Johnson & Johnson to end global sales of talc-based baby powder Johnson & Johnson has announced it will stop selling talc-based baby powder globally in 2023, more than two years after it ended US sales due to thousands of consumer safety lawsuits. Sky News - Published on August 12, 2022
Opioid epidemic: Native American tribes reach settlements of $590m with J&J and three distributors Native American tribes have reached settlements of $590m (£436m) with a pharmaceutical company and three distribution firms over the toll of opioids. Sky News - Published on February 2, 2022
India set to get first J&J Covid vaccine doses in October, says source India expects to get its first Johnson & Johnson Covid-19 vaccine doses from next month, filled and finished in India by a partner of the US drugmaker, a source with knowledge of the matter told.. IndiaTimes - Published on September 20, 2021
‘J&J should prioritise supply of locally-made Covid-19 jabs to India’ IndiaTimes - Published on September 16, 2021

Johnson & Johnson's single-shot vaccine likely to be rolled out in India by October Johnson & Johnson's single-shot vaccine was the fifth vaccine to get Emergency Use Approval for use in India by Drug Controller General on August 7. DNA - Published on September 9, 2021
Johnson and Johnson seeks nod to study Covid-19 vaccine among kids in India IndiaTimes - Published on August 20, 2021
Covid-19: Johnson & Johnson seeks approval to conduct vaccine trials for 12-17 age group Johnson & Johnson has submitted an application to the central drugs standard control organisation (CDSCO) to conduct a study of its Covid-19 vaccine in India in adolescents aged 12-17 years. IndiaTimes - Published on August 20, 2021	Johnson & Johnson's single-dose Covid vax gets emergency use nod IndiaTimes - Published on August 7, 2021Also reported by •DNA
Johnson and Johnson’s Covid-19 vaccine gets nod for emergency use in India India has approved Johnson & Johnson's single-dose CoviD-19 vaccine for emergency use on Saturday, health minister Mansukh Mandaviya said in a tweet. This will further boost the country's collective.. IndiaTimes - Published on August 7, 2021Also reported by •DNA	Johnson & Johnson applies for Emergency Use Authorization of its single-dose Covid vaccine in India Johnson & Johnson has applied for Emergency Use Authorization (EUA) of its single-dose Covid-19 vaccine in India, the global healthcare major said on Friday. IndiaTimes - Published on August 6, 2021Also reported by •DNA
J&J withdraws plea to hold vaccine trials as govt relaxes norms IndiaTimes - Published on August 2, 2021	'J&J withdraws proposal for speedy vaccine approval in India' IndiaTimes - Published on August 2, 2021